TIR treatment induced a statistically significant increase in GLUT3 and GLUT4 mRNA expression (Fig
Among the most promising of these drugs is tirzepatide (TZP), a dual agonist of the glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors ( TZP has demonstrated remarkable efficacy in promoting weight loss and improving metabolic parameters, including glucose control, insulin sensitivity, and lipid profiles [5]
A new systematic review, published in the online journal PLOS medicine, sought to critically review the evidence supporting the use of aripiprazole in the maintenance treatment of bipolar disorder and examine how that evidence has been disseminated in the scientific literature
GLP-1 medications in Singapore Semaglutide and other GLP-1 RAs in Singapore Key Takeaways Powerful Tools for Health: GLP-1 receptor agonists (like semaglutide, liraglutide, dulaglutide) and the newer dual-action agonist Tirzepatide are highly effective injectable medications for significantly improving blood sugar control in type 2 diabetes and promoting substantial weight loss in individuals with obesity or excess weight
Nuestro equipo es dedicada a exigir responsabilidades a las empresas farmacuticas y velando por la proteccin de los derechos de los pacientes